|
|
|
|
| LEADER |
01628nmm a2200349 u 4500 |
| 001 |
EB001902377 |
| 003 |
EBX01000000000000001065286 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
201006 ||| eng |
| 100 |
1 |
|
|a Smith, Peter G.
|
| 245 |
0 |
0 |
|a Human challenge trials for vaccines against COVID-19
|h Elektronische Ressource
|c Peter G. Smith
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2020, 2020
|
| 300 |
|
|
|a 1 streaming audio file (19 min.))
|
| 505 |
0 |
|
|a Contents: Study design of human challenge trials and comparison with classical clinical trials -- Previous vaccines tested in human challenge trials -- How human challenge trials accelerate vaccine development -- Drawbacks, limitations, and potential ethical issues -- Possible COVID-19 vaccine candidates for human challenge trials
|
| 653 |
|
|
|a severe acute respiratory syndrome coronavirus 2
|
| 653 |
|
|
|a Clinical Trials as Topic / methods
|
| 653 |
|
|
|a Clinical trials / Methodology
|
| 653 |
|
|
|a COVID-19 Vaccine
|
| 653 |
|
|
|a Clinical Trials as Topic / ethics
|
| 653 |
|
|
|a Clinical trials / Moral and ethical aspects
|
| 653 |
|
|
|a Covid-19 (Disease) / Vaccination
|
| 653 |
|
|
|a Research Design
|
| 653 |
|
|
|a COVID-19 / immunology
|
| 653 |
|
|
|a Vaccines / Development
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Research and clinical interviews
|
| 500 |
|
|
|a Audio interview. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/1060
|3 Series
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/4337
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|